1 cradle loop barrel
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Benzenoids | 154 | 69.2 | 2.23× | q < 0.0001 | |
| Organic acids and derivatives | 261 | 146.5 | 1.78× | q < 0.0001 | |
| Phenylpropanoids and polyketides | 34 | 19.7 | 1.73× | q = 5.5e-3 | |
| Organosulfur compounds | 32 | 19.5 | 1.64× | q = 0.01 | |
| Organic nitrogen compounds | 46 | 30.2 | 1.52× | q = 1.0e-2 | |
| Organoheterocyclic compounds | 155 | 145.7 | 1.06× | q = 0.47 | |
| Homogeneous non-metal compounds | 198 | 203.7 | 0.97× | q = 0.76 | |
| Nucleosides, nucleotides, and analogues | 245 | 261.7 | 0.94× | q = 0.30 | |
| Homogeneous metal compounds | 423 | 464.6 | 0.91× | q = 0.01 | |
| Organic oxygen compounds | 144 | 188.5 | 0.76× | q = 5.4e-4 | |
| Hydrocarbons | 5 | 6.6 | 0.76× | q = 0.76 | |
| Mixed metal/non-metal compounds | 14 | 19.9 | 0.70× | q = 0.28 | |
| Lipids and lipid-like molecules | 26 | 105.4 | 0.25× | q < 0.0001 | |
| Organic salts | 1 | 1.0 | 1.02× | not tested | |
| Organohalogen compounds | 2 | 2.7 | 0.74× | not tested | |
| Organometallic compounds | 1 | 1.4 | 0.74× | not tested | |
| Alkaloids and derivatives | 1 | 3.2 | 0.31× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03147 | FAD | Flavin adenine dinucleotide | 471 |
| DB00141 | NAG | N-Acetylglucosamine | 369 |
| DB00114 | PLP | Pyridoxal phosphate | 173 |
| DB03247 | FMN | Flavin mononucleotide | 162 |
| DB01264 | 017 | Darunavir | 161 |
| DB02078 | PG5 | Triglyme | 98 |
| DB03461 | NAP | Nicotinamide adenine dinucleotide phosphate | 96 |
| DB00171 | ATP | ATP | 71 |
| DB01232 | ROC | Saquinavir | 65 |
| DB09459 | TLA | L-tartaric acid | 62 |
| DB03345 | BME | Mercaptoethanol | 59 |
| DB00701 | 478 | Amprenavir | 54 |
| DB16833 | ADP | Adenosine disphosphate | 43 |
| DB00224 | MK1 | Indinavir | 36 |
| DB06841 | 0G6 | [(2R)-1-[(2S)-2-[[(2S,3S)-1-Chloro-6-(diaminomethylideneamino)-2-hydroxyhexan-3-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]azanium | 35 |
| DB00503 | RIT | Ritonavir | 33 |
| DB02313 | AG7 | Ethyl (4R)-4-{[(2R,5S)-2-(4-fluorobenzyl)-6-methyl-5-{[(5-methyl-1,2-oxazol-3-yl)carbonyl]amino}-4-oxoheptanoyl]amino}-5-[(3S)-2-oxo-3-pyrrolidinyl]pentanoate | 32 |
| DB03913 | F42 | Coenzyme F420 | 31 |
| DB18834 | 7YY | Ensitrelvir | 31 |
| DB01694 | TAR | D-tartaric acid | 29 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 3,110 |
| CL | CHLORIDE ION | 1,352 |
| ZNmetal | ZINC ION | 1,297 |
| CAmetal | CALCIUM ION | 1,242 |
| NAmetal | SODIUM ION | 923 |
| FAD | FLAVIN-ADENINE DINUCLEOTIDE | 522 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 511 |
| Kmetal | POTASSIUM ION | 277 |
| MNmetal | MANGANESE (II) ION | 241 |
| BEN | BENZAMIDINE | 197 |
| MGD | 2-AMINO-5,6-DIMERCAPTO-7-METHYL-3,7,8A,9-TETRAHYDRO-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-4-ONE GUANOSINE DINUCLEOTIDE | 189 |
| IOD | IODIDE ION | 187 |
| 017 | (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE | 168 |
| PLP | PYRIDOXAL-5'-PHOSPHATE | 166 |
| FMN | FLAVIN MONONUCLEOTIDE | 160 |
| OHX | osmium (III) hexammine | 145 |
| 4WI | (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide | 121 |
| PG5 | 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE | 105 |
| NAP | NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 93 |
| U1H | [4-(trifluoromethyl)phenyl]methanamine | 92 |